Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome
Not Applicable
- Conditions
- Metabolic Syndrome
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Les Derives Resiniques et Terpeniques
- Target Recruit Count
- 40
- Registration Number
- NCT04488653
- Locations
- 🇨🇦
KGK Science Inc., London, Ontario, Canada
News
No news found